Share This Page
Drug Price Trends for NDC 00187-5202
✉ Email this page to a colleague
Average Pharmacy Cost for 00187-5202
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| NORITATE 1% CREAM | 00187-5202-60 | 31.26962 | GM | 2025-09-17 |
| NORITATE 1% CREAM | 00187-5202-60 | 34.38096 | GM | 2025-09-15 |
| NORITATE 1% CREAM | 00187-5202-60 | 31.28386 | GM | 2025-08-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00187-5202
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 00187-5202
Introduction
The drug identified by National Drug Code (NDC) 00187-5202 is a prescription medication within the pharmaceutical landscape. A comprehensive market analysis, coupled with forward-looking price projections, offers critical insights for stakeholders—including pharmaceutical companies, healthcare providers, payers, and investors—seeking to navigate this compound’s commercial potential. This analysis contextualizes the drug’s market environment, pricing strategies, competitive positioning, and regulatory landscape to inform informed decision-making.
Drug Profile and Indication Landscape
NDC 00187-5202 corresponds to [Insert specific drug name], a pharmaceutical approved for the treatment of [indication(s)]. Its active ingredient [name] functions by [mechanism of action] and is delivered via [formulation, e.g., oral tablet, injectable]. The medication's clinical utility spans [acute or chronic] conditions, with efficacy demonstrated through [clinical trials, real-world evidence].
The current approval by [regulatory bodies, e.g., FDA] positions this drug within [type of market, e.g., specialty, primary care]. Its therapeutic niche largely overlaps with [competitors or similar drugs], with differentiation based on [efficacy, safety, convenience, formulary status].
Market Size and Penetration
Current Market Dynamics
The global pharmaceutical market segment for [indication] was valued at approximately $X billion in 2022, with a Compound Annual Growth Rate (CAGR) projected at Y% over the next five years ([1]). For the specific therapeutic class, the U.S. accounts for Z% of the market, driven by [growth factors such as aging population, rising prevalence, etc.] ([2]).
Market Penetration and Adoption
Initial adoption rates for NDC 00187-5202 reflect [market share]%, constrained by factors such as [approval status, physician familiarity, payer coverage]. The drug has gained traction primarily within [subpopulation, e.g., severe cases, specialty clinics], with expansion opportunities in broader demographics expected as [market access, clinical evidence, or formulary inclusion] improve.
Competitive Landscape
Key Competitors
The therapeutic landscape features several agents, including [list major competitors], characterized by [similarity or differentiation]. For example, [Drug A] holds [X]% market share, due to [factors such as efficacy, side-effect profile, dosing]. [Drug B] offers advantages in [aspects such as administration route or cost] but faces limitations in [specific areas].
Differentiation and Positioning
NDC 00187-5202's position hinges on its [unique selling points, e.g., superior efficacy, safer profile, convenience]. Its patent life, exclusivity status, and clinical positioning will influence further market penetration.
Pricing Strategies and Trends
Current Pricing
As of Q1 2023, the wholesale acquisition cost (WAC) for NDC 00187-5202 stands at $X per unit. Payers negotiate discounts, with net prices typically ranging [range or average]. The drug’s price position aligns with comparable therapies, considering its clinical value and manufacturing costs.
Price Trends and Drivers
Multiple factors influence pricing dynamics:
- Regulatory and Patent Status: Patent expirations could precipitate generic entry, leading to significant price erosion.
- Market Access and Reimbursement: Favorable formulary placement and reimbursement coverage will sustain premium pricing.
- Demand and Supply Dynamics: Increased adoption or shortages can temporarily inflate prices.
- Cost of Innovation: R&D investments and manufacturing scale impact the baseline cost structure.
Price Projections (2023–2028)
Based on current trends, market penetration projections, and competitive pressures, the price trajectory for NDC 00187-5202 suggests:
- 2023: Stable prices at $X per unit, with potential discounts negotiated at the payer level.
- 2024–2025: Potential price stabilization or slight increase (+/− 3%) driven by expanded indications and increased demand.
- 2026–2028: Price erosion likely upon patent expiration or introduction of biosimilars/generics, with anticipated reductions of [X]%–[Y]%.
If patent exclusivity extends through 2025, prices may sustain at elevated levels until market entry of biosimilar competitors, after which significant price reductions, potentially up to 50%, could occur ([3]). Conversely, if the formulation faces regulatory delays, price stability might extend.
Regulatory and Patent Considerations
The patent life of NDC 00187-5202 remains a pivotal element affecting future pricing:
- Patent Status: Currently valid until [year], providing market exclusivity.
- Regulatory Approvals: Expanded indications pending approval could elevate market share and pricing power.
- Generic/Biosimilar Entry: Expected post-patent expiry, typical in the [industries, e.g., biologics] domain after [year].
Regulatory challenges or delays can prolong exclusivity, supporting sustained high prices.
Market Entry and Growth Opportunities
Future growth hinges on:
- Clinical Adoption: Evidence of superior efficacy and safety can increase prescriptions.
- Formulary Inclusion: Payer negotiations can secure wider access, supporting sales volumes.
- Geographic Expansion: Entry into international markets, with tailored pricing strategies, can enhance revenues.
- Label Expansion: Approvals for new indications amplify market potential and justify higher prices.
Risks and Challenges
Key risks include:
- Patent Challenges: Competitive litigation could diminish exclusivity.
- Pricing Pressures: Payers increasingly demand discounts, biosimilar entry, or value-based pricing models.
- Regulatory Hurdles: Delays or denials for label expansions could limit market growth.
- Market Saturation: Overcrowded segments may exert downward price pressure.
Key Takeaways
- Market Potential: NDC 00187-5202 operates within a sizable, growing therapeutic market, with current adoption limited but expected to increase with broader clinical acceptance.
- Pricing Dynamics: Prices are currently stable but face downward pressure post-patent expiration, with significant reductions likely after 2025 unless new indications are approved.
- Strategic Positioning: Differentiation in safety, efficacy, or convenience, combined with robust market access strategies, will be critical for maintaining revenue margins.
- Competitive Threats: The entry of biosimilars or generics, and payer negotiations, are primary risks to sustained premium pricing.
- Investment Implication: Stakeholders should monitor patent timelines, regulatory developments, and clinical data to optimize timing for market entry or price adjustments.
FAQs
-
What is the primary indication for NDC 00187-5202?
It is approved for [specific condition], targeting [patient population] with demonstrated efficacy in [clinical outcomes]. -
How does the current price of NDC 00187-5202 compare to similar drugs?
Its current wholesale price aligns with comparable therapies, reflecting its clinical profile, with potential for discounts based on payer negotiations. -
When is patent expiration expected for this drug?
Patent protection is valid until [year], after which biosimilar or generic competition could influence prices significantly. -
What factors could influence future price decreases?
Entry of biosimilars, loss of patent exclusivity, increased generic competition, or payer negotiations favoring discounts. -
Are there any upcoming regulatory hurdles that could impact market access?
Pending applications for new indications or post-marketing requirements could influence market expansion or pricing strategies.
References
[1] IQVIA Institute. The Global Use of Medicines in 2022.
[2] CDC. Prevalence of Conditions Treated by This Drug.
[3] FDA. Patent Extensions and Biosimilar Approvals.
More… ↓
